Clinical trial
Investigation of Clinical Efficacy of a New Mouthwash on Reducing Dental Plaque and Helping Prevent Gum Problems as Compared to a Control Mouthwash - a Six-month Study in Italy
Name
CRO-2020-12-PGN-MMW-ITA-YPZ
Description
This 6-month clinical study was designed to investigate clinical efficacy on plaque and gingivitis for the Meridol Base Mouthwash containing 0.2% zinc lactate, 0.17% amine fluoride and 0.0275% sodium fluoride as compared to a Negative Control Mouthwash containing 0.057% sodium fluoride after 3 and 6 months of product use.
Trial arms
Trial start
2021-03-08
Estimated PCD
2021-09-24
Trial end
2021-09-24
Status
Completed
Phase
Early phase I
Treatment
0.2% zinc lactate, 0.17% amine fluoride and 0.0275% sodium fluoride Mouthwash
mouthwash
Arms:
0.2% zinc lactate, 0.17% amine fluoride and 0.0275% sodium fluoride Mouthwash
0.057% sodium fluoride Mouthwash
mouthwash
Arms:
0.057% sodium fluoride Mouthwash
Size
80
Primary endpoint
Gingival inflammation
baseline
Gingival inflammation
3 months
Gingival inflammation
6 months
Eligibility criteria
Inclusion Criteria:
* Subjects, ages 18-70, inclusive.
* Availability for the six-month duration of the clinical research study.
* Good general health.
* Initial gingivitis index of at least 1.0 as determined by the use of the Loe-Silness Gingival Index.
* Initial plaque index of at least 1.5 as determined by the use of the Quigley-Hein Plaque Index.
* Signed Informed Consent Form
Exclusion Criteria:
* Presence of orthodontic bands.
* Tumor(s) of the soft or hard tissues of the oral cavity.
* Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone).
* Five or more carious lesions requiring immediate restorative treatment.
* Antibiotic use any time during the one-month period prior to entry into the study.
* Participation in any other clinical study or test panel within the one month prior to entry into the study.
* Dental prophylaxis during the past two weeks prior to baseline examinations.
* History of allergies to oral care/personal care consumer products or their ingredients.
* On any prescription medicines that might interfere with the study outcome.
* An existing medical condition that prohibits eating or drinking for periods up to 4 hours.
* History of alcohol or drug abuse.
* Self-reported pregnant or lactating subjects
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE3'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR']}}, 'enrollmentInfo': {'count': 80, 'type': 'ACTUAL'}}
Updated at
2023-04-20
1 organization
2 products
2 indications
Organization
Colgate-PalmoliveProduct
Sodium FluorideIndication
Dental PlaqueIndication
Periodontal Disease